Patent · US Active

Compounds for the treatment of epilepsy, neurodegenerative disorders and other CNS disorders

US11939324B2 · kind B2 · utility

0Cited by

7References

12Claims

0Family size

Assignees

ReMYND N.V. · BE
Katholieke Universiteit Leuven · BE

Inventors

Johan Gerard Griffioen · Kessel-Lo, BE
Katrien Princen · Heverlee, BE
Tom Van Dooren · Koningshooikt, BE
Arnaud Marchand · Leuven, BE
Amuri Kilonda · Tienen, BE
Sara Allasia · Mechelen, BE
Patrick Chaltin · Zétrud-Lumay, BE

Key dates

Filing date	Nov 22, 2022
Grant date	Mar 26, 2024
Priority date	—
Expiry date	Nov 22, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to a compound of formula (I) or a tautomer thereof, wherein R1, R2, R3, R4 and R5, have the same meaning as that defined in the claims and the description. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds and compositions for the prevention and/or treatment of epilepsy and/or neurodegenerative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.